WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS
· Delayed Price · Currency is USD
5.94
-0.09 (-1.49%)
Feb 27, 2025, 3:53 PM EST
WuXi Biologics Employees
WuXi Biologics had 12,740 employees as of December 31, 2023. The number of employees increased by 367 or 2.97% compared to the previous year.
Employees
12,740
Change (1Y)
367
Growth (1Y)
2.97%
Revenue / Employee
$189,417
Profits / Employee
$29,128
Market Cap
12.46B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
WuXi Biologics News
- 10 days ago - WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year - PRNewsWire
- 17 days ago - WuXi Biologics Recognized as ESG Top-Rated Company by Morningstar Sustainalytics - GuruFocus
- 18 days ago - WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year - PRNewsWire
- 5 weeks ago - WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade) - Seeking Alpha
- 7 weeks ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - The Wall Street Journal
- 7 weeks ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - WSJ
- 7 weeks ago - WuXi Bio to Sell Vaccine Facility to Merck for $500 Million - BNN Bloomberg
- 7 weeks ago - WuXi Biologics Announces Strategic Agreement with Candid Therapeutics - GuruFocus